Further studies need to be performed to elucidate whether the same molecular mechanism is involved in the SCF + G-CSF-enhanced myelin repair, and whether SCF + G-CSF treatment could be applied in other demyelination-related diseases. This evidence concerns the gene CSF3 and Peripheral demyelination.